Medicare Changes For Medtech In 2020: What’s Ahead
Executive Summary
The US Centers for Medicare and Medicaid Services (CMS) has finalized many new coverage policy decisions and coverage rules taking effect in 2020. Medtech Insight provides a review of what industry can expect this year from the Medicare agency.
You may also be interested in...
Final 2020 CMS Outpatient, ASC Payment Rules Broaden Patient Access To Medtech
The US Medicare agency is allowing more device procedures to be conducted at outpatient hospitals and ambulatory surgical centers (ASC), while approving several new devices for passthrough payments for three years under its Outpatient Prospective Payment System and ASC payment system final rule for 2020, released on 1 November.
CMS Releases Final 2020 Home-Health Rule On Payments For Home Infusion-Therapy Equipment
Suppliers of infusion pumps and related supplies for homebound patients are entitled to payment for each visit, including coverage of professional nursing services, training and education, and monitoring of patients, says a US Medicare agency 2020 final rule on home-health benefits released on 1 November.
US Medicare Agency Proposes Expanding Coverage Of Next-Generation Sequencing For Advanced Cancers
There is sufficient evidence to expand coverage of next-generation sequencing (NGS) as a diagnostic test for ovarian, breast or other advanced cancers if certain criteria are met, the Centers for Medicare and Medicaid Services wrote in a 30 October proposed decision memo.